ChargePoint Technology has appointed Andrew McCreadie as its new business development manager for Europe, Middle East, India and Africa (EMEIA). The company is a powder containment and aseptic transfer valve specialist.
McCreadie’s appointment is in response to the increased demand for its containment technologies from the aseptic and high potency pharmaceutical manufacturing sectors.
Malcolm Cunningham, head of sales for EMEIA at ChargePoint, said: “Andrew will be pivotal in supporting pharmaceutical manufacturers and OEMs in this region with their containment challenges and introducing new technologies for use in hazardous environments to the market.”
“India, for example, continues to experience exceptional growth rates in the pharmaceutical industry with more and more pharma companies setting up facilities in this region to benefit from a much more cost-efficient alternative to Europe and US. Our expanding team in the region will assist towards reaching our growth targets within these relatively untouched markets.”
McCreadie holds a Mechanical and Automotive Engineering degree from Sheffield Hallam University and having held positions at Palamatic and Bosch Thermotechnology, he has significant experience in hazardous equipment.
McCreadie joins the company to cover the Indian, Middle East and African territories as well as supporting the company’s channels in Italy and Greece.
McCreadie said: “India is emerging as a competitive outsourcing hub and is playing a major role in the global pharma industry in manufacturing APIs and intermediates for drug makers. Global pharma companies are establishing long term relationships with Indian manufacturing companies and contract research providers in the country and it is our goal to support the market with effective containment strategies. Growth in Italy is also a key focus for 2018 due to its strategic location with the growing pharmaceutical markets of the Middle East and the region’s increasing production of hormones."
“Being able to further support our sales channels in Italy allows ChargePoint Technology access to these emerging markets and provides direct links to the pharmaceutical equipment manufacturers in those territories.”
